News & Media

Pitching at the Merck Innovation Challenge

Thang Vo-Ta
Co-Founder & CEO

What a privilege it was for Lara and I to present Calla Lily Clinical Care to senior members of Merck Group and M Ventures . Selected out of 100+ women’s health startups from around the world, we were able to share our vision for our transformational Callavid drug delivery platform, beginning with pregnancy & fertility. 🌸

Engaging and learning from Merck Healthcare’s global fertility and business development leaders was such a valuable experience. As any founder will attest to, there’s no end to opinions (and noise) out there about strategy, and particularly those who question why we have chosen to initially focus on the delivery of “simple” progesterone. I came away from such helpful and rewarding dialogue more resolutely focused than ever that we’re on the right path. 📈

Thank you to the 8 Merck “dragons” for the insightful feedback and rich engagement, and special thanks to Nathan and the SiS: Women’s Health team for facilitating such a fantastic event. 🙏

我們使用 cookies 來增強您的網站體驗。我們使用必要的 cookies 來確保我們的網站功能正常,並保持其安全性。這些 cookies 需要一直開啟。透過點擊「接受 Cookies」,同意Cookies 儲存您的設備,以增強網站導航,分析網站使用情況,並協助我們的營銷工作。請參閱我們的私隱政策獲取更多詳情。